METASTASES TO THORAX

This adverse event was reported 253 times

These drugs are most commonly taken by patients reporting METASTASES TO THORAX:

# Drug Count
0 FULVESTRANT 47
1 LETROZOLE 45
2 RIBOCICLIB 39
3 EVEROLIMUS 27
4 ANASTROZOLE 26
5 LETROZOLE TABLETS 26
6 EXEMESTANE 24
7 ANASTROZOLE TABLETS 20
8 OCTREOTIDE ACETATE 20
9 CAPECITABINE 18
See all common drugs associated with METASTASES TO THORAX

METASTASES TO THORAX is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 COUMARIN 2 0.0122
1 LULICONAZOLE 1 0.0057
2 FULVESTRANT 47 0.0014
3 AMIFOSTINE 1 0.0012
4 RIBOCICLIB 39 0.0012
5 AMILORIDE HYDROCHLORIDE 1 0.0012
6 EXEMESTANE 24 0.0011
7 FLUTAMIDE 1 0.0010
8 ANASTROZOLE TABLETS 20 0.0009
9 ERLOTINIB HYDROCHLORIDE 11 0.0009
See all drugs enriched for association with METASTASES TO THORAX

METASTASES TO THORAX is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Estrogen Receptor Antagonist [EPC] 47 0.0012
1 Aldehyde Dehydrogenase Inhibitor [EPC] 1 0.0009
2 Aromatase Inhibitor [EPC] 58 0.0005
3 Calcitonin [EPC] 1 0.0003
4 Sulfonamide Antibacterial [EPC] 1 0.0003
5 Progestin Antagonist [EPC] 1 0.0002
6 Programmed Death Ligand-1 Blocker [EPC] 4 0.0002
7 Somatostatin Analog [EPC] 1 0.0001
8 Cannabinoid [EPC] 1 0.0001
9 Anticholinergic [EPC] 2 0.0001
See all drug classes enriched for association with METASTASES TO THORAX